Showing results (61-70 of 101) with videos related to

Sort By:
Pageof 11
Springerplus|August 21, 2014
Complete resolution of steroid-resistant organizing pneumonia associated with myelodysplastic syndrome following allogeneic hematopoietic cell transplantationTakeru Asano, Nobuharu Fujii, Daigo Niiya, et al.
Transfusion|February 29, 2024
Collection efficiency and safety of large-volume leukapheresis for the manufacturing of tisagenlecleucelWataru Kitamura, Tomohiro Urata, Keiko Fujii, et al.
Transfusion|October 4, 2023
Evaluating the efficiency and safety of large-volume leukapheresis using the Spectra Optia continuous mononuclear cell collection protocol for peripheral blood stem cell collection from healthy donors: A retrospective studyYuichi Sumii, Keiko Fujii, Takumi Kondo, et al.
Cytotherapy|February 1, 2017
Graft-versus-leukemia effect with a WT1-specific T-cell response induced by azacitidine and donor lymphocyte infusions after allogeneic hematopoietic stem cell transplantationTatsunori Ishikawa, Nobuharu Fujii, Masahide Imada, et al.
Transfusion|September 9, 2022
Red blood cell depletion in small-volume bone marrow processing using manipulation with third-party red blood cells: A comparison of the performance of the COBE spectra and the spectra Optia systemsYuichi Sumii, Nobuharu Fujii, Keiko Fujii, et al.
International Journal of Hematology|December 16, 2024
Outcomes of allogeneic SCT versus tisagenlecleucel in patients with R/R LBCL and poor prognostic factorsKenta Hayashino, Toshiki Terao, Hisakazu Nishimori, et al.
Case Reports in Oncology|January 13, 2023
Sequential Combination of FLAM and Venetoclax plus Azacitidine to Bridge to Cord Blood Transplantation in a Patient with Primary Induction Failure Acute Myeloid LeukemiaHiroyuki Murakami, Ken-Ichi Matsuoka, Takeru Asano, et al.
International Journal of Hematology|February 4, 2022
Possible prognostic impact of WT1 mRNA expression at day + 30 after haploidentical peripheral blood stem cell transplantation with posttransplant cyclophosphamide for patients with myeloid neoplasm: a multicenter study from the Okayama Hematological Study GroupWataru Kitamura, Nobuharu Fujii, Yuichiro Nawa, et al.
International Journal of Hematology|June 13, 2025
A successful control of cardiac amyloidosis by idecabtagene vicleucel in a patient with relapsed and refractory multiple myeloma: a case report and literature reviewYayoi Ueda, Toshiki Terao, Nobuharu Fujii, et al.
Annals of Hematology|February 24, 2025
A randomized controlled trial of conventional GVHD prophylaxis with or without teprenone for the prevention of severe acute GVHDWataru Kitamura, Keiko Fujii, Mitsuru Tsuge, et al.
Pageof 11